Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.